Research On The Development Strategy Of X Pharmaceutical Company

At present,the global economic downturn in the context of the global outbreak of COVID-19,the Russia-Ukraine conflict,the Us-China trade war and other complex political and economic situations has caused a serious impact on the vigorous development of the pharmaceutical industry.In order to further improve the People’s Daily living standards,reduce the cost of medical care,reduce the price of drugs and related health care products,China has implemented the purchase with quantity.Through purchasing with quantity,the links in the circulation of drugs will be reduced,so that the price of drugs will be reduced,and the profits of drug manufacturers will be greatly reduced.Faced with the high cost of generic drug consistency evaluation and the reduction of drug profits,pharmaceutical enterprises reduce r&d investment,which has a certain impact on the pharmaceutical CRO industry.At the same time,the increasing number of domestic CRO companies leads to more fierce competition in the industry.X Pharmaceutical Company is a high-tech enterprise,its main business is to provide pre-clinical research and clinical research services.In the face of complex political environment and fierce competition,how to develop rapidly has become an urgent problem for X Pharmaceutical Company.From the perspective of the development process of domestic CRO industry and the framework of relevant theories of strategic management,this paper is completed under the guidance of my tutor by referring to relevant literatures of strategic management and pharmaceutical industry.In this paper,the strengths and weaknesses of X Pharmaceutical Company are determined through the analysis of its internal environment,and the opportunities and threats faced by the company are determined through the analysis of its external environment.Finally,the SWOT model is used to analyze the development strategy for X Pharmaceutical Company to choose.According to the guiding ideology and principles formulated by X Pharmaceutical Company’s development strategy,the company’s future development vision and goals are determined,the company’s development strategy at the company level and business level is determined,and corresponding guarantee measures are formulated.According to the research,X Pharmaceutical Company should choose a compound strategy based on vertical integration strategy combined with product diversification strategy,that is,through vertical integration strategy to reduce product production,product diversification strategy to improve products,so as to improve the core competitiveness of X Pharmaceutical Company.